For the quarter ending 2026-03-31, MGNX made $20,775,000 in revenue. -$36,833,000 in net income. Net profit margin of -177.29%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 20,775,000 | 41,228,000 | 72,839,000 | 22,241,000 |
| Cost of product sales | - | 0 | 0 | 0 |
| Cost of manufacturing services | 9,530,000 | 10,114,000 | 11,589,000 | 8,906,000 |
| Research and development | 34,974,000 | 33,974,000 | 32,709,000 | 40,791,000 |
| General and administrative | 9,710,000 | 9,235,000 | 9,905,000 | 9,302,000 |
| Total costs and expenses | 54,214,000 | 53,323,000 | 54,203,000 | 58,999,000 |
| Loss from operations | -33,439,000 | -12,095,000 | 18,636,000 | -36,758,000 |
| Gain on royalty monetization arrangement | - | 0* | - | - |
| Gain on sale of margenza | - | 0* | - | - |
| Interest and other income | 1,554,000 | 1,644,000* | 1,528,000 | 1,414,000 |
| Interest and other expense | 4,889,000 | 4,533,500* | 3,342,000 | 802,000 |
| Loss before income taxes | - | -14,984,500* | 16,822,000 | -36,146,000 |
| Income tax (benefit) expense | - | -829,500* | 0 | 105,000 |
| Net loss | -36,774,000 | -14,155,000 | 16,822,000 | -36,251,000 |
| Unrealized loss on investments | -59,000 | 27,000 | 12,000 | -6,000 |
| Comprehensive loss | -36,833,000 | -14,128,000 | 16,834,000 | -36,257,000 |
| Basic EPS | -0.58 | -0.223 | 0.27 | -0.57 |
| Diluted EPS | -0.58 | -0.223 | 0.27 | -0.57 |
| Basic Average Shares | 63,449,780 | 63,285,646 | 63,233,266 | 63,136,057 |
| Diluted Average Shares | 63,449,780 | 63,235,288 | 63,283,624 | 63,136,057 |
MACROGENICS INC (MGNX)
MACROGENICS INC (MGNX)